The following statements regarding tissue plasminogen activator are true, except:
It is produced by recombinant DNA technology. Induction of systemic lytic state is limited with its use. It is ineffective in lysing thrombi of myocardial infarction. It is a poor plasminogen activator in the absence of fibrin.